About HemoSense
HemoSense is a company based in San Jose (United States) founded in 1997 was acquired by Abbott in November 2007.. HemoSense has raised $17.7 million across 2 funding rounds from investors including Tredegar, Abbott Global Point of Care and NEA. HemoSense operates in a competitive market with competitors including Hemosonics, Stasys, Exactus, ClotChip and Atantares, among others.
- Headquarter San Jose, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of HemoSense
HemoSense has successfully raised a total of $17.7M across 2 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7 million completed in December 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $7.0M
-
First Round
First Round
(06 Oct 2000)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2006 | Amount | Post-IPO - HemoSense | Valuation |
investors |
|
| Oct, 2000 | Amount | Series C - HemoSense | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in HemoSense
HemoSense has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Tredegar, Abbott Global Point of Care and NEA. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Invests in biotech firms developing life-saving drugs and technologies.
|
Founded Year | Domain | Location | |
|
Plastic films and aluminum products are manufactured by Tredegar.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HemoSense
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - HemoSense
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Hemosense Comparisons
Competitors of HemoSense
HemoSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hemosonics, Stasys, Exactus, ClotChip and Atantares, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
IVD for hemostasis characterization
|
|
| domain | founded_year | HQ Location |
Provider of POC device for analyzing blood clotting disorders and platelet dysfunction
|
|
| domain | founded_year | HQ Location |
POC diagnostics for fibrinolytic status assessment are developed.
|
|
| domain | founded_year | HQ Location |
Portable tests for blood coagulation analysis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of precision medicines & smart diagnostic devices by fusing biochip and AI technologies
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about HemoSense
When was HemoSense founded?
HemoSense was founded in 1997 and raised its 1st funding round 3 years after it was founded.
Where is HemoSense located?
HemoSense is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is HemoSense a funded company?
HemoSense is a funded company, having raised a total of $17.7M across 2 funding rounds to date. The company's 1st funding round was a Series C of $17.7M, raised on Oct 06, 2000.
What does HemoSense do?
HemoSense was founded in 1997 in San Jose, United States, and focused on the medical device sector. Development, manufacturing, and marketing of handheld systems for monitoring blood coagulation in warfarin patients were conducted. The INRatio System was provided to measure clotting time at the point of care. Acquisition by Alere Diagnostics occurred in 2013.
Who are the top competitors of HemoSense?
HemoSense's top competitors include Hemosonics, Perosphere Technologies and Atantares.
Who are HemoSense's investors?
HemoSense has 4 investors. Key investors include Tredegar, Abbott Global Point of Care, NEA, and Turmeric Acquisition Corp.